venBio Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
93
- Portfolio
-
27
- Exits
-
43

venBio General Information
Company Description
Founded in 2011, VenBio is a venture capital firm based in San Francisco, California. The firm seeks to invest in the healthcare sector with a focus on drug discovery. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.venbio.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1700 Owens Street
- Suite 595
- San Francisco, CA 94158
- United States
venBio Investments (93)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Attovia | 21-Jan-2025 | Early Stage VC | Biotechnology | Pre-Clinical Trials | ||
35Pharma | 22-Nov-2024 | Biotechnology | Clinical Trials - General | |||
Axonis Therapeutics | 30-Oct-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
ViceBio | 23-Sep-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
Candid Therapeutics | 20-Aug-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
Marea (Biotechnology) | 11-Jun-2024 | Biotechnology | Clinical Trials - Phase 1 | |||
Alumis | 29-May-2024 | Drug Discovery | Generating Revenue | |||
Aeovian Pharmaceuticals | 13-May-2024 | Drug Discovery | Generating Revenue | |||
ImmPACT Bio | 01-Apr-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
Axonis Therapeutics | 22-Mar-2024 | Seed Round | Drug Discovery | Clinical Trials - Phase 1 |
venBio Exits (43)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ImmPACT Bio | 31-Oct-2024 | Merger/Acquisition | |
Artiva | 19-Jul-2024 | ||
Alumis | 28-Jun-2024 | ||
IPI Legacy Liquidation | 19-Dec-2023 | ||
RayzeBio | 15-Sep-2023 | ||
Acelyrin | 05-May-2023 | ||
Akero Therapeutics | 17-Jun-2022 | ||
Checkmate Pharmaceuticals | 31-May-2022 | ||
Stargazer Pharmaceuticals | 30-Mar-2022 | Out of Business | |
CinCor Pharma | 07-Jan-2022 | IPO |
venBio Investments by Industry, Year, and Region
venBio Co-Investors (167)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Logos Capital | 9 |
![]() |
![]() |
||
Samsara BioCapital |
![]() |
![]() |
|||
Vivo Capital |
![]() |
![]() |
|||
Cormorant Asset Management |
![]() |
![]() |
|||
Surveyor Capital |
![]() |
![]() |
venBio FAQs
-
What is venBio?
Founded in 2011, VenBio is a venture capital firm based in San Francisco, California.
-
When was venBio founded?
venBio was founded in 2011.
-
Where is venBio headquartered?
venBio is headquartered in San Francisco, CA.
-
What is venBio's total asset value?
venBio has around
in total assets under management. -
How many investments has venBio made?
venBio has made 93 investments.
-
What has venBio invested in?
venBio has made numerous investments in companies like Attovia, 35Pharma, and Axonis Therapeutics within the Biotechnology and Drug Discovery industries.
-
What has venBio invested in recently?
venBio's latest investment was on 21-Jan-2025 in Attovia, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »